Expanding the expanded risk score to psoriatic arthritis: any port in a storm. [PDF]
Favalli EG +5 more
europepmc +1 more source
Tildrakizumab as a Potential Option for Early Psoriatic Arthritis in Patients with Metabolic Comorbidities and Psoriasis: a Case Series. [PDF]
Artosi F +10 more
europepmc +1 more source
Eosinophilia Induced by Biosimilar Adalimumab (CinnoRA) in a Patient with Psoriasis and Psoriatic Arthritis: A Case Report. [PDF]
Saedpanah R, Rashidi A, Firooz A.
europepmc +1 more source
Letter to the Editor Regarding "Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study". [PDF]
Borras-Blasco J +2 more
europepmc +1 more source
Anti-PCNA antibodies in psoriatic arthritis: a case-control study. [PDF]
Fitzpatrick R +5 more
europepmc +1 more source
RETRACTION: Mendelian Randomization Analysis of Psoriasis and Psoriatic Arthritis Associated With Risks of Ulcerative Colitis. [PDF]
europepmc +1 more source
Hyperuricemia in psoriatic arthritis: clinical correlations and implications. [PDF]
Tabra SA, Aly HM, Ghanem S, Abu-Zaid MH.
europepmc +1 more source
Characterization of antibodies for osteopontin fragments in rheumatoid arthritis [PDF]
Sharif, Shadi
core +1 more source

